News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
310,123 Results
Type
Article (18428)
Company Profile (35)
Press Release (291660)
Multimedia
Podcasts (21)
Webinars (9)
Section
Business (81635)
Career Advice (163)
Deals (12728)
Drug Delivery (38)
Drug Development (37464)
Employer Resources (20)
FDA (5376)
Job Trends (4199)
News (136123)
Policy (10489)
Tag
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (681)
Accelerated approval (32)
ADA (26)
Adcomms (3)
Allergies (115)
Alliances (22205)
ALS (114)
Alzheimer's disease (648)
Antibody-drug conjugate (ADC) (339)
Approvals (5832)
Artificial intelligence (371)
ASCO (203)
Autoimmune disease (275)
Automation (30)
Bankruptcy (83)
Best Places to Work (3649)
BIO (31)
Biosimilars (103)
Biotechnology (26)
Bladder cancer (151)
Brain cancer (31)
Breast cancer (497)
Cancer (3887)
Cardiovascular disease (281)
Career advice (145)
Career pathing (4)
CAR-T (246)
CDC (12)
Celiac Disease (1)
Cell therapy (566)
Cervical cancer (22)
Clinical research (34287)
Collaboration (1206)
Compensation (601)
Complete response letters (26)
COVID-19 (2039)
CRISPR (70)
C-suite (690)
Cystic fibrosis (82)
Data (5422)
Decentralized trials (1)
Denatured (1)
Depression (81)
Dermatology (69)
Diabetes (289)
Diagnostics (2434)
Digital health (21)
Diversity (4)
Diversity, equity & inclusion (6)
Drug discovery (175)
Drug pricing (43)
Drug shortages (7)
Duchenne muscular dystrophy (127)
Earnings (26655)
Editorial (10)
Employer branding (2)
Employer resources (21)
Events (56085)
Executive appointments (692)
FDA (7588)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (8)
Frontotemporal dementia (15)
Funding (1074)
Gene editing (137)
Generative AI (26)
Gene therapy (333)
GLP-1 (372)
Government (1426)
Grass and pollen (6)
Guidances (249)
Healthcare (5050)
Hematology (117)
HIV (64)
Huntington's disease (36)
IgA nephropathy (87)
Immunology and inflammation (156)
Immuno-oncology (63)
Indications (128)
Infectious disease (2253)
Inflammatory bowel disease (122)
Inflation Reduction Act (5)
Influenza (93)
Intellectual property (127)
Interviews (30)
IPO (5002)
IRA (8)
Job creations (884)
Job search strategy (126)
JPM (17)
Kidney cancer (12)
Labor market (10)
Layoffs (107)
Leadership (4)
Legal (2386)
Liver cancer (59)
Longevity (9)
Lung cancer (518)
Lymphoma (430)
Machine learning (28)
Management (5)
Manufacturing (431)
Marketing (3)
MASH (141)
Medical device (3032)
Medtech (3092)
Mergers & acquisitions (8421)
Metabolic disorders (709)
mRNA (104)
Multiple sclerosis (129)
NASH (10)
Neurodegenerative disease (234)
Neuropsychiatric disorders (48)
Neuroscience (1472)
NextGen: Class of 2026 (1576)
Non-profit (637)
Now hiring (3)
Obesity (263)
Opinion (127)
Ovarian cancer (153)
Pain (120)
Pancreatic cancer (213)
Parkinson's disease (209)
Partnered (10)
Patents (254)
Patient recruitment (458)
Peanut (40)
People (34999)
Pharmaceutical (10)
Pharmacy benefit managers (9)
Phase 1 (11564)
Phase 2 (15738)
Phase 3 (10548)
Pipeline (5873)
Policy (53)
Postmarket research (1008)
Preclinical (4158)
Press Release (16)
Prostate cancer (209)
Psychedelics (13)
Radiopharmaceuticals (113)
Rare diseases (589)
Real estate (1739)
Recruiting (11)
Regulatory (9454)
Reports (9)
Research institute (672)
Resumes & cover letters (20)
Rett syndrome (34)
RNA editing (15)
RSV (56)
Schizophrenia (75)
Series A (170)
Series B (251)
Service/supplier (2)
Sickle cell disease (65)
Special edition (5)
Spinal muscular atrophy (69)
Sponsored (13)
Startups (1926)
Stomach cancer (5)
Supply chain (53)
Tariffs (20)
The Weekly (20)
Vaccines (574)
Venture capital (55)
Weight loss (148)
Women's health (58)
Date
Today (44)
Last 7 days (219)
Last 30 days (1094)
Last 365 days (15957)
2026 (8734)
2025 (16071)
2024 (14139)
2023 (13780)
2022 (19280)
2021 (22406)
2020 (19414)
2019 (10453)
2018 (7945)
2017 (14273)
2016 (16847)
2015 (21247)
2014 (15945)
2013 (13441)
2012 (13882)
2011 (13558)
2010 (11844)
Location
Africa (293)
Alabama (37)
Arizona (97)
Arkansas (9)
Asia (19181)
Australia (2863)
California (7731)
Canada (1826)
China (776)
Colorado (322)
Connecticut (375)
Delaware (300)
Europe (46370)
Florida (891)
Georgia (238)
Hawaii (3)
Idaho (17)
Illinois (690)
India (45)
Indiana (197)
Iowa (11)
Japan (390)
Kansas (59)
Kentucky (18)
Louisiana (24)
Maine (11)
Maryland (739)
Massachusetts (5672)
Michigan (126)
Minnesota (295)
Mississippi (1)
Missouri (71)
Montana (10)
Nebraska (4)
Nevada (105)
New Hampshire (25)
New Jersey (1993)
New Mexico (8)
New York (1843)
North Carolina (769)
North Dakota (5)
Northern California (4092)
Ohio (182)
Oklahoma (7)
Oregon (16)
Pennsylvania (1174)
Puerto Rico (9)
Rhode Island (19)
South America (534)
South Carolina (11)
Southern California (2885)
Tennessee (75)
Texas (1274)
United States (25504)
Utah (116)
Virginia (173)
Washington D.C. (28)
Washington State (616)
West Virginia (1)
Wisconsin (114)
Wyoming (1)
310,123 Results for "cergentis b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
AstraZeneca bets up to $1.9B in respiratory disease collab with Sino Biopharmaceutical
In AstraZeneca’s third trip to Asia this year, the pharma secured ex-China rights to a dual inhibitor of PDE3 and PDE4, which in a Phase 2b study significantly improved lung function and lowered symptom burden in patients with chronic obstructive pulmonary disorder.
July 8, 2026
·
2 min read
·
Tristan Manalac
Job Trends
Ones to watch: 4 biotechs with recent Series B raises (that are also hiring)
Biopharmas that announced Series B financing this year and are looking for employees as they grow include two companies that received $100 million or more. One has partnerships with three Big Pharmas.
June 18, 2026
·
4 min read
·
Angela Gabriel
Press Releases
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
July 1, 2026
·
5 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
June 11, 2026
·
9 min read
Press Releases
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 15, 2025
·
3 min read
Press Releases
Reunion Neuroscience Announces Appointment of Sahil V. Kirpekar, M.D., as President and CEO
June 15, 2026
·
4 min read
Press Releases
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
October 20, 2025
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026
June 8, 2026
·
2 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
April 9, 2026
·
2 min read
Press Releases
Azenta Completes Sale of B Medical Systems
July 8, 2026
·
3 min read
1 of 31,013
Next
